tirzepatide category class is a first-in-class dual agonist targeting both GIP and GLP-1 receptors Understanding and Managing MOUNJARO® Therapy
Pay in 4 interest-free payments of $7.48 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25


























